Research Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With Asplenia.
Clinical trial NCT04166656 · RECRUITING
Trial details
- NCT number
- NCT04166656
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-15
- Primary completion
- 2028-09-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.